Supplies - 123918-2019

18/03/2019    S54

United Kingdom-Normanton: Medical equipments, pharmaceuticals and personal care products

2019/S 054-123918

Prior information notice

This notice is for prior information only

Supplies

Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: DHL acting on behalf of Supply Chain Coordination Ltd acting on behalf of the NHS Business Services Authority
National registration number: 528867
Postal address: Foxbridge Way
Town: Normanton
NUTS code: UKE4 West Yorkshire
Postal code: WF6 1TL
Country: United Kingdom
Contact person: Sarah Styles
E-mail: sarah.styles@supplychain.nhs.uk
Telephone: +44 7783150482
Fax: +44 1924328744
Internet address(es):
Main address: www.supplychain.nhs.uk
I.2)Information about joint procurement
The contract is awarded by a central purchasing body
I.3)Communication
Additional information can be obtained from the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at: http://procurement.supplychain.nhs.uk/ISS
I.4)Type of the contracting authority
National or federal agency/office
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Skin Cleansing and Disinfection

II.1.2)Main CPV code
33000000 Medical equipments, pharmaceuticals and personal care products
II.1.3)Type of contract
Supplies
II.1.4)Short description:

The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months for the supply of skin cleansing and disinfection products for patient use, including but not limited to hand hygiene products, skin wipes, patient cleansing products, localised skin disinfectant, body decolonisation products biocides and LMP skin and body disinfectants. Precise quantities are unknown, initial expenditure in the first year including growth is expected to be in the region of 33 186 250 GBP. The estimated value over the total Framework Agreement term will be in the region of 138 117 860 GBP.

II.1.5)Estimated total value
Value excluding VAT: 138 117 860.00 GBP
II.1.6)Information about lots
This contract is divided into lots: yes
Maximum number of lots that may be awarded to one tenderer: 6
II.2)Description
II.2.1)Title:

Hand Hygiene

Lot No: 1
II.2.2)Additional CPV code(s)
33631600 Antiseptics and disinfectants
33711500 Skin-care products
33711900 Soap
33741000 Hand care products
33741300 Hand sanitizer
33700000 Personal care products
33740000 Hand and nails care products
33741100 Hand cleaner
33741200 Hand or body lotions
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

Products included in this lot that are within scope for this lot include but are not limited to:

Handwash,

Alcohol free hand sanitiser,

Hand sanitiser,

Moisturiser,

Dispensers and accessories such as belt clips, drip trays etc.

The requirement may include assistance/ training around the intended use of the products and aftercare such as auditing. Evidence of compliance with the Cosmetics Directive, Biocidal Regulations and Medical Devices Directive may also be required.

Some of these products areas may be subject to clinical evaluation as part of the tender process.

Products may be supplied via the Stock, Blue Diamond and E-Direct routes to market.

II.2.14)Additional information

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £7,612,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

II.2)Description
II.2.1)Title:

Skin Wipes

Lot No: 2
II.2.2)Additional CPV code(s)
33141118 Wipes
33711430 Disposable personal wipes
33711500 Skin-care products
33741000 Hand care products
33700000 Personal care products
33740000 Hand and nails care products
33741100 Hand cleaner
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

Skin wipes for patient cleansing. Products included in this lot that are within scope for this lot include but are not limited to:

Hand and face wipes,

Bed bath wipes and

Continence wipes.

The requirement may include assistance/ training around the intended use of the products and aftercare such as auditing. Evidence of compliance with the Cosmetics Directive, Biocidal Regulations and Medical Devices Directive may also be required.

Some of these product areas maybe subject to clinical evaluation as part of the tender process.

Products may be supplied via the Stock, Blue Diamond and E-Direct routes to market.

II.2.14)Additional information

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £4,095,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

II.2)Description
II.2.1)Title:

Patient Cleansing Products

Lot No: 3
II.2.2)Additional CPV code(s)
33700000 Personal care products
33741000 Hand care products
33711900 Soap
33711000 Perfumes and toiletries
33711600 Hair preparations and articles
33711610 Shampoos
33740000 Hand and nails care products
33741100 Hand cleaner
33741200 Hand or body lotions
33711500 Skin-care products
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

Hygiene products for patient cleansing. Products included in this lot that are within scope for this lot include but are not limited to:

Shampoo,

Shampoo caps,

Shower gel,

Bodywash,

Mouthwash,

Tablet soap and

Baby bath.

The requirement may include assistance/ training around the intended use of the products and aftercare such as auditing. Evidence of compliance with the Cosmetics Directive, Biocidal Regulations, Medicines Act 1968 (as amended) and Medical Devices Directive may also be required.

Some of these product areas maybe subject to clinical evaluation as part of the tender process.

Products may be supplied via the Stock, Blue Diamond and E-Direct routes to market.

II.2.14)Additional information

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £1,155,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

II.2)Description
II.2.1)Title:

Localised Skin Disinfection

Lot No: 4
II.2.2)Additional CPV code(s)
33631600 Antiseptics and disinfectants
33141118 Wipes
33711430 Disposable personal wipes
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

Skin disinfection products for localised general skin disinfection. Products included in this lot that are within scope for this lot include but are not limited to:

Skin disinfectants biocidal products for general skin disinfection,

Skin cleansing/pre-injection swabs for adhesive removal and skin cleansing containing 70 % IPA,

Skin cleansing wipes containing 2 % Chlorhexidine in 70 % IPA,

Dispensers and accessories such as drip trays.

The requirement may include assistance/ training around the intended use of the products and aftercare such as auditing. Evidence of compliance with the Cosmetics Directive, Biocidal Regulations and Medical Devices Directive may also be required.

Some of these product areas maybe subject to clinical evaluation as part of the tender process.

Products may be supplied via the Stock, Blue Diamond and E-Direct routes to market.

II.2.14)Additional information

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £1,575,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

II.2)Description
II.2.1)Title:

Body Decolonisation Biocides

Lot No: 5
II.2.2)Additional CPV code(s)
33631600 Antiseptics and disinfectants
33711600 Hair preparations and articles
33711610 Shampoos
33711700 Articles and preparations for oral or dental hygiene
33711740 Mouthwash
33741200 Hand or body lotions
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

Antimicrobial products for body decolonisation. Products included in this lot that are within scope for this lot include but are not limited to:

Body wash,

Mouthwash,

Shampoo caps and nasal gels.

The requirement may include assistance/ training around the intended use of the products and aftercare such as auditing. Evidence of compliance with the Biocidal Regulations maybe required.

Products may be supplied via the Stock, Blue Diamond and E-Direct routes to market.

II.2.14)Additional information

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £1,680,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

II.2)Description
II.2.1)Title:

LMP Skin and Body Disinfection Products

Lot No: 6
II.2.2)Additional CPV code(s)
33631600 Antiseptics and disinfectants
33141118 Wipes
33711700 Articles and preparations for oral or dental hygiene
33711740 Mouthwash
33690000 Various medicinal products
33600000 Pharmaceutical products
II.2.3)Place of performance
NUTS code: UK UNITED KINGDOM
II.2.4)Description of the procurement:

Products included in this lot that are within scope for this lot include but are not limited to:

Products used for skin disinfection classified as licensed medical products with or without an applicator and containing either Chlorhexidine, Povidone Iodine or other suitable active disinfectant ingredient(s).

The requirement may include assistance/ training around the intended use of the products and aftercare such as auditing. Evidence of compliance with the Medicines Act 1968 (as amended) may also be required.

Some of these product areas maybe subject to clinical evaluation as part of the tender process.

Products may be supplied via the Stock, Blue Diamond and E-Direct routes to market.

II.2.14)Additional information

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £17,144,250 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.

II.3)Estimated date of publication of contract notice:
16/09/2019

Section IV: Procedure

IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no

Section VI: Complementary information

VI.3)Additional information:

Certification will be a requirement of the upcoming tender exercise and applicants will be required to include evidence of this with their tender submission.

ISO 9001:2015 or equivalent externally accredited and up-to-date quality standard certificate(s) to cover all segments of the applicant's (and the product's) supply chain. This should include but not be limited to manufacturing storage and distribution. Further information in respect of certification requirements will be set out in the notice for the forthcoming procurement. If such certificates are not in the name of the applicant then the applicant must supply a copy of agreements setting out the authority and responsibilities of all parties in the supply chain.

The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.

The Framework Agreement will be between NHS Supply Chain and the Supplier. Under the Framework Agreement, the supply method will be non-direct contract products.

NHS Supply Chain will be entitled to purchase the supplies and/or services identified in the tender documents as non-direct contract products which it will then make available for purchase by:

1) Any NHS Trust;

2) Any other NHS entity;

3) Any government department, agency or other statutory body; and/or

4) Any private sector entity active in the UK healthcare sector.

NHS Supply Chain is currently considering the use of lots for this procurement. However, it reserves the right not to as part of any future tender process. Further information in respect of the lot strategy will be set out in the notice for the forthcoming procurement.

As part of its pre-tender strategy, NHS Supply Chain would also like to engage with suppliers of these products via a Request for Information (RFI). if you could complete the Request for Information document in respect of the products which are the subject of this procurement then please follow the below instructions;

Candidates wishing to complete the Request for Information must register their expression of interest. The Request for Information document will then be sent via the Intenda Messaging Centre.

Registration:

1) Use URL http://procurement.supplychain.nhs.uk/ISS/ to access the NHS Supply Chain Procurement portal.

2) If not yet registered:

— click on the “Not Registered Yet” link to access the registration page,

— complete the registration pages as guided by the mini guide found on the landing page.

Portal access

If registration has been completed:

— login with URL http://procurement.supplychain.nhs.uk/ISS/,

— click on the “Applicant Dashboard” icon to open the list of new procurement events.

Expression of interest:

— view PIN content by clicking on the “View Notice” button for the procurement event. This opens a PDF document,

— express an interest by clicking on the “Express Interest” button.

Request for information document:

— the request for information document will then be sent to you via the Intenda Messaging Centre,

— applicants will then have 3 months from the dispatch of this notice to complete and return the Request for Information document.

VI.5)Date of dispatch of this notice:
13/03/2019